News Search Results
Sep 17, 2025, 07:32 ET Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
Canada, and Japan. It has a pipeline of 20 biosimilar assets across diabetology, oncology, immunology, ophthalmology, bone health and other non-communicable diseases. The Company has many 'firsts' to its credit in the biosimilars industry. As part of its environmental,
More news about: Biocon Biologics
Sep 16, 2025, 15:06 ET Parker Waichman LLP Files Lawsuit on Behalf of Baltimore Resident Alleging Irreversible Eye Condition After Taking Ozempic
drug to NAION, a permanent condition that cuts off blood flow to the optic nerve and can result in blindness. A 2025 study in JAMA Ophthalmology reported multiple cases of optic nerve disorders among GLP-1 users, most with NAION-like symptoms. Separately,
More news about: Parker Waichman LLP
Sep 16, 2025, 09:00 ET ExSight Ventures Invests in RevOpsis Therapeutics to Advance Innovative Treatments for Blinding Eye Diseases
Sept. 16, 2025 /PRNewswire/ -- ExSight Ventures, a venture capital firm dedicated to investing in transformative ophthalmology innovations, today announced its investment in RevOpsis Therapeutics, a biotechnology company pioneering next-generation therapies for retinal
More news about: RevOpsis
Sep 16, 2025, 07:33 ET Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Sep 16, 2025, 07:25 ET Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Sep 16, 2025, 01:00 ET Happiest Health Announces Ethics in Healthcare Summit 2025: A Platform for Trust, Transparency & Reform
individuals to take charge of their health. The Healthcare Services (HCS) division offers Dental services, with more disciplines like ENT, Ophthalmology, Dermatology and Orthopaedics being added soon. Our Wellness division provides Ayurveda, Physiotherapy, and Yoga clinics with a Mental Health
More news about: Happiest Health Systems Pvt LTD
Sep 15, 2025, 21:00 ET Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025
that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announces that it will present multiple research results at the 34th European Academy of Dermatology and Venereology
More news about: Innovent Biologics
Sep 15, 2025, 14:04 ET Global Busbar Market Driven by Rising Demand for Energy Efficiency and Power Distribution Solutions - Market Research Intellect
Lasers Market is categorized based on Product (Diode Lasers, CO₂ Lasers, Er:YAG Lasers, Nd:YAG Lasers, Alexandrite Lasers) and Application (Ophthalmology, Dermatology & Aesthetics, Dentistry, Urology, Gynecology) and geographical regions
More news about: Market Research Intellect
Sep 15, 2025, 07:00 ET New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
Meeting in Chicago, Illinois. Dr. Charles Wykoff, MD, PhD, Deputy Chair of Ophthalmology, Blanton Eye Institute, presented continuing data from the three-arm, open-label Phase 1b APEX study of KSI-101 for
More news about: Kodiak Sciences Inc.
Sep 15, 2025, 01:54 ET Mann Eye Institute Welcomes Internationally Renowned Ophthalmic Oncology Expert Dr. Bita Esmaeli
2024, she served as a tenured Professor of Ophthalmology at The University of Texas M. D. Anderson Cancer Center in Houston, where she held leadership roles including Chief of the Section of Ophthalmology from 1998 to 2004 and Ophthalmic Plastic
More news about: Mann Eye Institute
Sep 12, 2025, 09:04 ET Haag-Streit USA announces US launch of Elara 900 and Refractor 900
American Academy of Ophthalmology (AAO) annual meeting in October.
More news about: Haag-Streit USA
Sep 11, 2025, 13:22 ET Why Ophthalmology Surgery Centers Are Choosing NorthStar for Anesthesia Partnership
IRVING, Texas, Sept. 11, 2025 /PRNewswire/ -- Ophthalmology surgery centers nationwide are increasingly choosing NorthStar Anesthesia as their trusted partner for anesthesia care. With a model purpose-built
More news about: NorthStar Anesthesia
Sep 11, 2025, 01:12 ET PRIVACY ALERT: Retina Group of Florida Under Investigation for Data Breach of 152,691 Patient Records
of 152,691 patients of Retina Group of Florida. Retina Group of Florida is an ophthalmology practice that operates 23 retina clinics in East, South and Southwest Gulf Coast Florida.
More news about: Schubert Jonckheer & Kolbe LLP
Sep 10, 2025, 09:00 ET Luminopia Partners with Pokémon to Expand Its Curated Content Library for Pediatric Amblyopia Patients
results were published in Ophthalmology, leading to the initial FDA approval for patients aged 4 to 7 years. Based on the robust real-world evidence collected through the PUPiL Registry,
More news about: Luminopia
Sep 09, 2025, 17:31 ET Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight
public health concern. Greater disease detection & screening efforts Improved screening programs, wider use of OCT and tele-ophthalmology, and growing awareness mean more early diagnoses, which increases lifetime treatment uptake (drops, combination therapy, procedures). This enlarges
More news about: DelveInsight Business Research, LLP
Sep 09, 2025, 10:01 ET Next Generation Antibody Therapeutics Market Size will Hit $22.88 Billion by 2033, Fueled by Breakthroughs in Oncology and AI-Driven Drug Design | DataM Intelligence
and patient compliance. Antibody fragments and scaffolds, although comparatively smaller in size, showcased high growth potential, especially in ophthalmology and inflammatory diseases, contributing over US$ 0.9 billion in 2024. By Therapeutic Area Oncology
More news about: DataM Intelligence 4 Market Research LLP
Sep 09, 2025, 08:15 ET DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Return Capital to the Shareholders
If InMode is likely to experience higher future sales – as it continues to innovate, taking current technology into new areas such as urology and ophthalmology and invests in R&D, while maintaining SG&A at a high level, waiting for the market to recover – buybacks are the right tool to generate
More news about: DOMA Perpetual
Sep 08, 2025, 11:00 ET ABMS Announces a Record Number of ABMS Scholars for the 2025-2026 Cohort
ABMS Member Board participants include: Allergy and Immunology, Dermatology, Emergency Medicine, Internal Medicine, Obstetrics and Gynecology, Ophthalmology, Orthopaedic Surgery, Pediatrics, Physical Medicine and Rehabilitation, Radiology, Surgery, and Urology. This ABMS Scholars cohort will begin
More news about: American Board of Medical Specialties
Sep 07, 2025, 20:30 ET Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress
that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, announced that the results of the Phase 2 clinical study of the xanthine oxidase inhibitor (XOI) tigulixostat (R&D
More news about: Innovent Biologics
Sep 03, 2025, 11:55 ET VirtuaLens Launches Immersive Virtual Reality IOL Simulator, Transforming Cataract Patient Education and Lens Selection
Cataract surgery is among the most frequently performed and life-changing procedures in ophthalmology, with millions of cases carried out annually globally, including several million in the United States alone. Despite
More news about: VirtuaLens
Sep 03, 2025, 10:45 ET Ophthalmic Imaging Market worth US$3.84 billion by 2030 with 6.3% CAGR | MarketsandMarkets™
major restraints, limiting accessibility and implementation, especially in low-resource settings. Key opportunities include the expansion of tele-ophthalmology, increased healthcare investments in emerging economies, and the growing need for early, accurate detection of vision-threatening conditions.
More news about: MarketsandMarkets
Sep 03, 2025, 10:15 ET Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR - Verified Market Reports®
System Market Size By Product Type (Softwares, Hardware), By Application (Retinal Imaging, Anterior Segment Imaging), By End-User (Hospitals, Ophthalmology Clinics), By Deployment Mode (Cloud-based Solutions, On-premise Solutions), By Technology Type (Artificial Intelligence, Machine Learning), By Geographic
More news about: Verified Market Reports
Sep 03, 2025, 05:30 ET Acer Medical Unveils aiMed Ahead of IFA 2025, Showcasing the Future of AI in Healthcare
secure cloud-based architecture further ensures data protection. Acer Medical also provides the VeriSee platform, an AI-assisted ophthalmology analysis platform. It can integrate multiple existing and new AI modules, allowing doctors to select and use them based on different clinical needs.
More news about: Acer Medical
Sep 02, 2025, 11:14 ET CorNeat Vision's Artificial Cornea Restores Perfect 20/20 Vision in Shingles-Blinded Eye
lives. At Beilinson's Ophthalmology Department, we are committed to leading with cutting-edge technologies, and this breakthrough reflects our mission to bring the future of eye care into the present." said Prof. Irit Bahar, Head of Ophthalmology, Beilinson Hospital
More news about: CorNeat Vision
Sep 02, 2025, 08:30 ET InMode to Present at Baird 2025 Global Healthcare Conference
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com. Forward-Looking
More news about: InMode Ltd.